AROCELL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.373 SEK | +0.27% |
|
-1.32% | -14.65% |
| Apr. 18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
| Feb. 22 | AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart calendar AroCell AB
3936a7f403dd0301abdc8b7fd3c.-lf_HJF_yESQkj-IVlFAjvzd1fPOeHY2pQBNGxqxr4I.zWSRT_pLgz3UxGrhZGF2zLqCj6r_G0VVzzUBQ3_F5PLDL6BM3BmQceimeg~c2e526fd32de7cecc77009ac36816461
Upcoming events on AroCell AB
Past events on AroCell AB
| 2024-02-21 | Q4 2023 Earnings Release |
| 2024-01-24 08:21 am | Redeye Theme: Fight Cancer |
| 2023-10-24 | Q3 2023 Earnings Release |
| 2023-08-22 | Q2 2023 Earnings Release |
| 2023-05-23 | Annual General Meeting |
| 2023-05-09 | Redeye Medtech Forum |
| 2023-04-27 | Q1 2023 Earnings Release |
| 2023-02-22 | FY 2022 Earnings Release |
| 2022-11-28 | BioStock Life Science Fall Summit 2022 |
| 2022-11-21 | Strategy Update Call |
| 2022-11-10 | Q3 2022 Earnings Release |
| 2022-08-16 | Interim 2022 Earnings Release |
| 2022-05-23 | Annual General Meeting |
| 2022-05-17 | Q1 2022 Earnings Release |
| 2022-02-23 | FY 2021 Earnings Release |
| 2021-11-11 | Q3 2021 Earnings Release |
| 2021-08-19 | Interim 2021 Earnings Release |
| 2021-05-12 | Q1 2021 Earnings Release |
| 2021-05-05 | Annual General Meeting |
| 2021-02-18 | FY 2020 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,44 0,50 -11.4% | 0,00 | 12,0 23,0 -47.84% | 37,0 35,0 5.67% | 43,0 45,1 -4.57% | 61,0 |
|
EBITDA Million SEK | Released Forecast Spread | -17,3 -22,0 21.2% | 0,00 | -26,0 -32,0 18.78% | -14,3 -12,0 -18.76% | 0,00 -13,1 - | -6,90 |
|
EBIT Million SEK | Released Forecast Spread | -20,7 -22,0 5.75% | 0,00 | -50,6 -56,0 9.69% | -59,3 -56,0 -5.9% | -59,8 -57,4 -4.15% | -51,2 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -20,7 -22,0 5.75% | 0,00 | 0,00 0,00 - | -59,0 -56,0 -5.31% | -59,3 -57,0 -4.03% | -51,0 |
|
Net income Million SEK | Released Forecast Spread | -20,7 -22,0 5.75% | -24,1 | 0,00 0,00 - | -59,0 -56,0 -5.31% | -59,3 -57,0 -4.03% | -51,0 |
|
EPS SEK | Released Forecast Spread | -0,53 -0,29 -82.76% | -0,33 | 0,00 0,00 - | -0,28 -0,50 44% | -0,26 -0,20 -30% | -0,20 |
| Announcement Date | 21/02/20 | 19/02/21 | 07/04/22 | 23/02/23 | 12/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 7,77 6,50 19.54% | 6,35 8,10 -21.62% | 10,4 7,70 35.08% | 12,5 10,7 16.55% | 11,1 13,1 -15.63% | 11,8 12,8 -8.01% | 10,7 13,3 -19.55% | 9,51 11,6 -18.01% | 12,3 | 15,1 | 16,5 | 17,1 | |
|
EBITDA Million SEK | Released Forecast Spread | -10,6 -8,10 -31.11% | -10,9 5,80 -288.62% | -5,99 -4,50 -33.11% | -2,30 | -1,30 | -3,40 | -3,50 | -3,90 | -3,20 | -2,40 | -1,00 | -0,30 | |
|
EBIT Million SEK | Released Forecast Spread | -15,7 -19,1 17.83% | -16,0 -17,0 5.8% | -11,1 -15,7 29.5% | -16,5 -13,4 -23.34% | -13,7 -12,4 -10.24% | -15,5 -14,5 -6.79% | -13,3 -14,6 9.14% | -17,4 -14,9 -16.54% | -14,3 | -13,4 | -12,1 | -11,4 | |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -20,2 7,00 -389.24% | -15,7 -19,1 17.83% | -16,0 -17,0 5.79% | ||||||||||
|
Net income Million SEK | Released Forecast Spread | -15,5 -19,1 18.92% | -15,9 -17,0 6.48% | |||||||||||
| Announcement Date | 07/04/22 | 29/04/22 | 17/08/22 | 27/10/22 | 23/02/23 | 03/05/23 | 23/08/23 | 02/11/23 | 12/04/24 | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for AroCell AB
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AROC Stock
- Calendar AroCell AB
